Roche's Gazyva wins Breakthrough Therapy status for lupus ne...
Roche’s Gazyva has won Breakthrough Therapy status for its potential new use in the autoimmune disease lupus nephritis, as the Swiss pharma attempts to breathe new life into the drug curren
